Designerly's Cooper Adwin looks at why generative AI Is re-engineering skin rejuvenation and phasing out animal collagen.

At LIC 2026, investors, scientists and founders examined what survives the journey from longevity hypothesis to human ...

A five-year NIA grant puts UCLA Health in charge of checking whether AI tools for Alzheimer’s care work before they spread.

New Singapore masterclass will give senior leaders three days to turn geroscience, personal data and market evidence into ...

The company says its four-year lifespan screen found 60+ life-extending compounds, and a new advisory board will help chase them.

Chinese biotechs can run trials 50–70% faster – our report shows where that speed is paying off, and where the road narrows.

AbbVie’s JUVMO (tavapadon) targets dopamine differently from older drugs and is expected in US pharmacies this month, the ...

Mito now offers a coronary artery calcium scan without a referral. Here’s what it shows, what it costs and what a zero doesn't promise.

At ARDD 2026, senior FDA officials sketch how a therapy targeting aging might one day reach approval, revealing that ...

Pharma has the podium as Novo and Lilly stop talking about GLP-1 longevity and start measuring it, bringing early aging data ...

As peptides surge in popularity, better evidence and cleaner supply chains could help the field grow without leaving patients ...